Last update 14 Jun 2025

Levocabastine Hydrochloride/Mometasone furoate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mometasone furoate/levocabastine hydrochloride, CKD-342
Target
GR x H1 receptor
Action
agonists, antagonists
Mechanism
GR agonists(Glucocorticoid receptor agonists), H1 receptor antagonists(Histamine H1 receptor antagonists)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication-
Inactive Indication
Rhinitis, Allergic, Perennial
Originator Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
Active Organization-
Inactive Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H30ClFN2O2
InChIKeyOICFWWJHIMKBCD-VALQNVSPSA-N
CAS Registry79547-78-7
View All Structures (2)

Related

1
Clinical Trials associated with Levocabastine Hydrochloride/Mometasone furoate
NCT02498509
/ CompletedPhase 3
A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Concomitant Mometasone Furoate and Levocabastine HCl in Perennial Allergic Rhinitis Patients
100 Clinical Results associated with Levocabastine Hydrochloride/Mometasone furoate
Login to view more data
100 Translational Medicine associated with Levocabastine Hydrochloride/Mometasone furoate
Login to view more data
100 Patents (Medical) associated with Levocabastine Hydrochloride/Mometasone furoate
Login to view more data
100 Deals associated with Levocabastine Hydrochloride/Mometasone furoate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rhinitis, Allergic, PerennialPhase 3
United States
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
01 May 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free